{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T10:20:15Z","timestamp":1780482015388,"version":"3.54.1"},"reference-count":38,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2001,5,1]],"date-time":"2001-05-01T00:00:00Z","timestamp":988675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Infect Immun"],"published-print":{"date-parts":[[2001,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>C57BL\/6 mice were vaccinated with plasmid DNA encoding Ag85 from<jats:italic>Mycobacterium tuberculosis<\/jats:italic>, with Ag85 protein in adjuvant, or with a combined DNA prime-protein boost regimen. While DNA immunization, as previously described, induced robust Th1-type cytokine responses, protein-in-adjuvant vaccination elicited very poor cytokine responses, which were 10-fold lower than those observed with DNA immunization alone. Injection of Ag85 DNA-primed mice with 30 to 100 \u03bcg of purified Ag85 protein in adjuvant increased the interleukin-2 and gamma interferon (IFN-\u03b3) response in spleen two- to fourfold. Further, intracellular cytokine analysis by flow cytometry also showed an increase in IFN-\u03b3-producing CD4<jats:sup>+<\/jats:sup>T cells in DNA-primed\u2013protein-boosted animals, compared to those that received only the DNA vaccination. Moreover, these responses appeared to be better sustained over time. Antibodies were readily produced by all three methods of immunization but were exclusively of the immunoglobulin G1 (IgG1) isotype following protein immunization in adjuvant and preferentially of the IgG2a isotype following DNA and DNA prime-protein boost vaccination. Finally, protein boosting increased the protective efficacy of the DNA vaccine against an intravenous<jats:italic>M. tuberculosis<\/jats:italic>H37Rv challenge infection, as measured by CFU or relative light unit counts in lungs 1 and 2 months after infection. The capacity of exogenously given protein to boost the DNA-primed vaccination effect underlines the dominant role of Th1-type CD4<jats:sup>+<\/jats:sup>helper T cells in mediating protection.<\/jats:p>","DOI":"10.1128\/iai.69.5.3041-3047.2001","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:01:19Z","timestamp":1027764079000},"page":"3041-3047","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":148,"title":["Improved Immunogenicity and Protective Efficacy of a Tuberculosis DNA Vaccine Encoding Ag85 by Protein Boosting"],"prefix":"10.1128","volume":"69","author":[{"given":"Audrey","family":"Tanghe","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Pasteur Institute of Brussels, Mycobacterial Immunology, B1180 Brussels,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushila","family":"D'Souza","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Pasteur Institute of Brussels, Mycobacterial Immunology, B1180 Brussels,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vale\u0301rie","family":"Rosseels","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Pasteur Institute of Brussels, Mycobacterial Immunology, B1180 Brussels,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Denis","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Pasteur Institute of Brussels, Mycobacterial Immunology, B1180 Brussels,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H. M.","family":"Ottenhoff","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Leiden University Medical Center, ZA 2333, Leiden, The Netherlands2; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfried","family":"Dalemans","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->SmithKline Beecham Biologicals, B1330 Rixensart,3 Belgium;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Wheeler","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Vical Incorporated, San Diego, California 921214"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris","family":"Huygen","sequence":"additional","affiliation":[{"name":"<!--label omitted: 1-->Pasteur Institute of Brussels, Mycobacterial Immunology, B1180 Brussels,1 and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.6.2536-2544.1994"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1054\/tuld.1998.0196"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(96)00264-2"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5317.1420"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Bloom B. R. Fine P. E. M. The BCG experience: implications for future vaccines against tuberculosis Tuberculosis: pathogenesis protection and control. Bloom B. R. 1994 531 557 ASM Press Washington D.C.","DOI":"10.1128\/9781555818357.ch31"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1054\/tuld.1998.0200"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.55.1.245-252.1987"},{"key":"e_1_3_2_9_2","first-page":"331","article-title":"The 32 kDa protein antigen of M. bovis B.C.G. and M. tuberculosis H37Rv","volume":"41","author":"De Bruyn J.","year":"1990","unstructured":"De Bruyn J. Huygen K. Van Vooren J. P. Content J. Turneer M. The 32 kDa protein antigen of M. bovis B.C.G. and M. tuberculosis H37Rv.Trop. Med. Parasitol.411990331332","journal-title":"Trop. Med. Parasitol."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.66.4.1527-1533.1998"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/1521-4141(200009)30:9<2455::AID-IMMU2455>3.0.CO;2-2"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.11.6463"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-3083.1999.00543.x"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00445-X"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.5.1530"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2249.1992.tb06419.x"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.7.2880-2886.1992"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0896-893"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.2.363-370.1994"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1999.01310.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.4.1702-1707.1999"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.4049\/jimmunol.161.8.4211","article-title":"Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite","volume":"161","author":"Kang Y.","year":"1998","unstructured":"Kang Y. Calvo P. A. Daly T. M. Long C. A. Comparison of humoral immune responses elicited by DNA and protein vaccines based on merozoite surface protein-1 from Plasmodium yoelii, a rodent malaria parasite.J. Immunol.161199842114219","journal-title":"J. Immunol."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1038\/79631"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.161.1.1"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1128\/iai.62.9.3679-3687.1994"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.17.9378"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1998.9379"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(00)01612-1"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.11.9092-9100.1998"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/72413"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0498-397"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1089\/104454999314917"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.165.12.7088"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.10.5223-5230.1999"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.67.9.4586-4593.1999"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.6.2920-2925.2000"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.7.3854-3860.2000"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.162.2.1113","article-title":"Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors","volume":"162","author":"Tanghe A.","year":"1999","unstructured":"Tanghe A. Lef\u00e8vre P. Denis O. D'Souza S. Braibant M. Lozes E. Singh M. Montgomery D. Content J. Huygen K. Immunogenicity and protective efficacy of tuberculosis DNA vaccines encoding putative phosphate transport receptors.J. Immunol.162199911131119","journal-title":"J. Immunol."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/mr.56.4.648-661.1992"}],"container-title":["Infection and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.5.3041-3047.2001","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/IAI.69.5.3041-3047.2001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T15:32:22Z","timestamp":1682263942000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/IAI.69.5.3041-3047.2001"}},"subtitle":[],"editor":[{"given":"D. L.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2001,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,5]]}},"alternative-id":["10.1128\/IAI.69.5.3041-3047.2001"],"URL":"https:\/\/doi.org\/10.1128\/iai.69.5.3041-3047.2001","relation":{},"ISSN":["0019-9567","1098-5522"],"issn-type":[{"value":"0019-9567","type":"print"},{"value":"1098-5522","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,5]]},"assertion":[{"value":"2000-11-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-02-08","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2001-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}